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Abstract
Background. Most studies underline the contribution of heritable factors for psychiatric dis-
orders. However, heritability estimates depend on the population under study, diagnostic
instruments, and study designs that each has its inherent assumptions, strengths, and biases.
We aim to test the homogeneity in heritability estimates between two powerful, and state of
the art study designs for eight psychiatric disorders.
Methods. We assessed heritability based on data of Swedish siblings (N = 4 408 646 full and
maternal half-siblings), and based on summary data of eight samples with measured geno-
types (N = 125 533 cases and 208 215 controls). All data were based on standard diagnostic
criteria. Eight psychiatric disorders were studied: (1) alcohol dependence (AD), (2) anorexia
nervosa, (3) attention deficit/hyperactivity disorder (ADHD), (4) autism spectrum disorder,
(5) bipolar disorder, (6) major depressive disorder, (7) obsessive-compulsive disorder
(OCD), and (8) schizophrenia.
Results. Heritability estimates from sibling data varied from 0.30 for Major Depression to
0.80 for ADHD. The estimates based on the measured genotypes were lower, ranging from
0.10 for AD to 0.28 for OCD, but were significant, and correlated positively (0.19) with
national sibling-based estimates. When removing OCD from the data the correlation
increased to 0.50.
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Conclusions. Given the unique character of each study design, the convergent findings for
these eight psychiatric conditions suggest that heritability estimates are robust across different
methods. The findings also highlight large differences in genetic and environmental influences
between psychiatric disorders, providing future directions for etiological psychiatric research.
Introduction
Psychiatric disorders place an enormous burden on medical
resources and society in general (Eaton et al., 2008; Petrou et al.,
2010). For most disorders, the causal factors are as yet largely
unknown which limits treatment options considerably. A better
understanding of the etiology of psychiatric disorders is a crucial
step towards advancing treatment and intervention strategies.
Twin studies showed that genetic factors play an important role in
the etiology of psychiatric traits. Heritability estimates (h2, i.e. the
inherited contribution of genetic variance to trait variance) range
from 35% for major depression to over 60% for schizophrenia
(SCZ) (Polderman et al., 2015). The remaining variance is explained
by non-genetic factors perhaps including non-identifiable environ-
mental factors. Another method to derive estimates of genetic and
environmental variance is the use of pedigree data (e.g. parents
and children, siblings and half-siblings) from large national registers
(Pettersson et al., 2016). Additionally, rapid methodological devel-
opments have recently advanced the use of summary data of
genome-wide association studies (GWAS) in which heritability is
inferred from the linkage disequilibrium scores (LDSC) of single
nucleotide polymorphisms (SNP) (i.e. the ability of a SNP to tag
other genetic variants) (Bulik-Sullivan et al., 2015). Yet, it is recog-
nized that these heritability estimates do not capture all genetic fac-
tors contributing to variance in the trait (such as rare genetic effects),
and hence can be viewed as lower bound estimates.
While heritability is conceptualized as a single population param-
eter, estimates depend on the population under study, ascertain-
ment, diagnostic instruments, and study design. Estimates may
also change over time due to variations in diagnostic criteria
(Zablotsky et al., 2015; Thomas et al., 2015), an increase in awareness
and detection of psychiatric disorders (Van Naarden Braun et al.,
2015), changes in the exposure to environmental factors (Rokholm
et al., 2011), or changes in social situations (Kendler et al., 2000).
Using two different methods, this study capitalizes on the largest
and most powerful data-sets to date, to estimate the heritability of
eight psychiatric conditions: (1) alcohol dependence (AD), (2) anor-
exia nervosa (AN), (3) attention deficit/hyperactivity disorder
(ADHD), (4) autism spectrum disorder (ASD), (5) bipolar disorder
(BIP), (6) major depressive disorder (MDD), (7) obsessive-
compulsive disorder (OCD), and (8) SCZ. First, we use a large
Swedish national cohort (h2-national) that currently includes over
20 million full and maternal half-sibling pairs. Unlike most twin
studies, the Swedish sibling sample uses clinical diagnoses derived
frommedical in- and out-patient treatment registers, instead of sur-
veys. Second, we use summary data of eight large samples of subjects
with measured SNPs (h2-SNP). The uniqueness is estimating herit-
ability from very large samples, based on genetic similarities inferred
from distantly related people. As in the h2-national design, case sta-
tus in the h2-SNP design is based on diagnostic criteria.
Although each study design has its own strengths, they also have
study-specific biases and assumptions (listed in Table 1). For
instance, in the national register data that we use, not all affected
individuals seek help or are correctly diagnosed. The sibling
method also relies on certain assumptions, such as a 100% shared
environment despite age differences between siblings, and despite
the fact that half-siblings might live in two families (with the bio-
logical mother and with the biological father) and thus spend
potentially less time together than full siblings (Moffitt et al.,
2010; Pettersson et al., 2016). However, confounding with shared
environmental factors is likely excluded in the h2-SNP design.
Yet, in contrast to sibling studies that assume to capture all possible
genetic effects, the h2-SNP analysis is based on genome-wide vari-
ation that is derived from a selection of common genetic variants
only (Vinkhuyzen et al., 2013). By including a large number of
observations from both study designs, our study is adequately pow-
ered to robustly estimate in each design the heritability, despite
relying on different sets of assumptions and methodologies.
The aim of this study is to provide a test of the homogeneity in
heritability estimates between family-based data (h2-national) and
SNP-based data for eight psychiatric conditions. Our hypothesis is
that h2-SNP is lower, but correlates positively with the family-
based estimates. In addition, our design can illustrate the differ-
ences in etiology between the psychiatric conditions, guiding
future directions for etiological research in psychiatry.
Method
National sibling cohort (h2-national)
Personal identification numbers unique to each individual in
Sweden were used to create a national population-based cohort
from which twins were excluded. Information was extracted
from the National Patient Register, which includes all public psychi-
atric inpatient diagnoses in Sweden since 1973 and outpatient diag-
noses since 2001, assigned by the attending physician with a
non-hierarchical diagnostic structure in accord with ICD version 8
(1969–1986), 9 (1987–1996), or 10 (1997–present). The ICD
codes for the eight disorders are presented in Table S1 in the
Supplementary. We used theMulti-Generation Register to link indi-
viduals to their full and maternal half-siblings registered as living in
Sweden since 1961 and born in Sweden since 1932. Only two siblings
per family were included, starting with the oldest siblings in each
family followed by the next oldest sibling, but only if born within
5 years of the first sibling to maximize the probability that they
had experienced a similar rearing (i.e. shared) environment. If the
two eldest were born more than 5 years apart, we proceeded to the
second oldest sibling pair within the family, and so on. The final
sample size of full- and maternal half-siblings varied by diagnosis.
To ensure that the younger sibling in each pair had lived long enough
to receive a potential diagnosis, pairs in which the younger sibling
was younger than 5 (for ADHD and ASD), 10 (for AD, AN,
MDD, and OCD), or 15 years old (BIP and SCZ) were excluded.
The sibling design assumes (a) that full siblings share an aver-
age of 50% of additive genetic effects and 25% of non-additive
genetic effects, (b) that maternal half-siblings share an average
of 25% of additive genetic effects and 0% of non-additive genetic
effects, and (c) that shared environmental effects are 100% shared
between both full and maternal half-siblings, and that (d) non-
shared environmental effects are unique to each individual.
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By comparing the observed tetrachoric correlations between the
binary diagnoses for full and maternal half-siblings, we estimated
the contribution of genetic variance (h2-national), and shared
and non-shared environmental variance. The analyses were
carried out in Mplus (Muthén and Muthén, 1998) using the
mean- and variance-adjusted unweighted least squares estimator.
We regressed out the effects of sex and age from all diagnoses. For
ADHD and ASD, we limited the birth year to 1990 and beyond
because these diagnoses only existed in ICD 9 and 10.
Genetic data (h2-SNP)
The h2-SNP estimates were based on the most recent available data
for all eight disorders in the Psychiatric Genomics Consortium
(PGC)(Psychiatric GWAS Consortium Coordinating Committee
et al., 2009; Psychiatric GWAS Consortium Steering Committee,
2009) (see Study cohort details in the Supplementary). The
LDSC approach was used to estimate the h2-SNP (Bulik-Sullivan
et al., 2015). In brief, this method is based on the LDSC of a
SNP, which reflects its ability to tag other SNPs. The more SNPs
are tagged, the higher the probability that this represents a poly-
genic signal instead. Therefore, by taking LD into account this
method is able to distinguish spurious associations due to popula-
tion stratification from the true polygenic signal. The LDSC
method is also robust to confounding due to shared environmental
effects, and is very efficient as it can be applied to GWAS summary
statistics (Evans et al., 2018). Of note, GWAS usually include mil-
lions of common variants, but not rare variants. The heritability
(h2-SNP), adjusted for the prevalence of the disorder, is inferred
from the slope of the regression.
Analyses
Differences in heritability estimates were tested using d = h1
2− h22,
S.E.d =
NameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMe
(S.E.h21)
2 + (S.E.h22)
2
√
. The ratio Z = d/S.E.(d) gives a test
of the null hypothesis that the difference d is zero, by comparing
the value of Z to the standard normal distribution(Altman and
Bland, 2003). A significance threshold of 0.05 was Bonferroni
corrected to accommodate multiple testing (i.e. a correction for
eight tests).
Results
Estimates of shared environmental effects were non-significant in
the sibling analyses. The heritability estimates (Fig. 1) showed
significant differences between the h2-national estimates and
the h2-SNP estimates. The latter were significantly lower (cor-
rected p < 0.02), except for AN, BIP, and OCD where the
h2-SNP estimates did not significantly differ from h2-national
(corrected p > 0.30). However, these differences should be inter-
preted with caution as due to the somewhat smaller samples
sizes of these particular disorders, the standard errors (S.E.) of
h2-national were relatively wide for AN, BIP, and OCD. Of
note, the S.E. is in general sensitive to sample size, and in particu-
lar for h2-national because the full and half-sibling groups only
differ by 0.25 in genetic relatedness. Additionally, the nature of
summary data of large consortium designs implies that included
samples have been genotyped on different platforms and chips,
potentially increasing the S.E. of h2-SNP.
Heritability estimates from the two designs correlated posi-
tively (r 0.19). However, this correlation was mainly driven by
OCD that showed the highest h2-SNP and lowest h2-national;
when removing OCD this correlation increased to 0.50. The
high h2-SNP is probably due to the fact that the OCD sample is
heavily ascertained from highly multiplex families and early age
of onset cases, and consists thus of the most severe and genetically
loaded cases.
Tables S2 and S3 in the Supplementary show detailed sample
characteristics of each study design.
Table 1. Strengths, limitations and assumptions of each study design in estimating heritability (h2) of psychiatric disorders
Study design Strengths Limitations Assumptions
National sibling
design (h2–national)
Implicitly includes effects of
common and rare genetic effects
No info on actual causal genetic variants Equal shared sibling
environment, also for half
siblings
Psychiatric status based on
clinical diagnosis
Needs large samples sizes (tens of thousands of
cases) to be able to estimate heritability
Random mating
Reflection of general
population
No gene × environment
interaction
No gene × environment
correlation
SNP-based design
(h2-SNP)
Based on measured genetic
variants
Includes (a priori) tagged common genetic effects
only
Random mating
No confounding with shared
environmental factors
Needs large samples sizes (hundreds of thousands of
cases and controls) to be able to extract small
genetic effects
Reflection of general
population
Psychiatric status based on
clinical diagnosis
No gene × environment
interaction
No gene × environment
correlation
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Discussion
We estimated the heritability of eight psychiatric conditions using
two different study designs: a national sibling design, and a
SNP-based design. Estimates derived from the two study designs
consistently show that all disorders are moderate to highly herit-
able but also showed large differences between disorders. The cor-
relation between the family-based and SNP-based estimates was
positive (0.50 when leaving out OCD) suggesting that a higher
family-based heritability is associated with a larger (aggregated)
effect of SNPs. This supports the hypothesis that, apart from
rare variants, common genetic variants play an important role
in psychiatric disorders, and thus confirms the polygenic nature
of these complex traits (Visscher et al., 2012).
The heritability estimates based on the large national sibling
study (h2-national) were remarkably similar to previous twin
studies of psychiatric traits (Polderman et al., 2015), despite dif-
ferent assessment strategies, with twin studies being survey-based,
and as such based on psychiatric trait measures, and the national
sibling study based on clinical diagnoses. This might suggest that
heritability estimates are robust across different diagnostic tools
and measures. It is also in line with studies that reported high
genetic correlations between survey-based psychiatric traits and
clinical diagnoses, e.g. for ASD (Colvert et al., 2015), ADHD
(Lubke et al., 2009), and psychosis (Zavos et al., 2014), suggesting
an overlap in genetic factors between psychiatric traits as mea-
sured in the general population and clinical disorders.
Heritability estimates based on SNP data (h2-SNP) were,
as expected, lower than the family-based designs (Yang et al.,
2017). An obvious explanation for these differences is that
h2-SNP is based on measured common (and not rare) genotypes,
whereas the other design is based on familial relationships and
hence includes estimates of genetic factors shared by relatives
that are rare in populations. The largest differences between
the family-based and h2-SNP estimates were observed for the
neurodevelopmental traits ADHD and ASD, and for SCZ.
Indeed, rare variant risk effects have been reported for ADHD,
ASD, and SCZ (Williams et al., 2010; Hiroi et al., 2013; Sanders
et al., 2015), although a recent well-powered study on SCZ showed
that the explained variance due to rare variants was about 20%
of the total explained variance (0.85% for rare variants v. 3.4%
for common variants) (CNV and Schizophrenia Working
Groups of the Psychiatric Genomics Consortium & Psychosis
Endophenotypes International Consortium, 2017).
Another explanation for the discrepancy between family-based
and SNP-based estimates for ADHD, ASD, and SCZ could be the
presence of non-additive effects resulting in overestimates of the
narrow-sense heritability in the family-based design, when non-
additive influences are removed from the statistical models.
Non-additive factors contributing to trait variance have indeed
been reported for ADHD (Rietveld et al., 2004). Lower h2-SNP
might also indicate the presence of disorder heterogeneity, that is,
a disorder is viewed as a single disorder but actually being a combin-
ation of disorder dimensions that has biologically distinct causal fac-
tors. As this affects GWAS, and hence h2-SNP, most substantially,
this explains the lower h2-SNP but is also informative about poten-
tially underlying disorder mechanisms (Wray andMaier, 2014). For
ADHD and ASD specifically, the inclusion of trio data (i.e. case-
pseudo control design) may have underestimated h2-SNP due to
an increased polygenic burden on the un-transmitted chromosomes
(Peyrot et al., 2016a), although the trio samples were small
compared with the much larger case-control samples.
In general, the nature of the large consortium designs on
which SNP-based heritability is based likely increases the stand-
ard error, all of which will impact on h2-SNP. The h2-SNP of
the eight psychiatric traits as observed in the current study should,
therefore, be considered as lower-bound estimates of SNP-
heritability. Interestingly, the smallest difference in family-based
and SNP-based estimates between both designs was for OCD
(respectively, 0.38% v. 0.28%). As mentioned previously, the
Fig. 1. h2-national and h2-SNP estimates ordered from low to high based on h2-national. Note: Error bars represent standard errors. AD, alcohol dependence; ADHD,
attention deficit/hyperactivity disorder; AN, anorexia nervosa; ASD, autism spectrum disorder; BIP, bipolar disorder; MDD, major depressive disorder; OCD,
obsessive-compulsive disorder; SCZ, schizophrenia.
4 E. Pettersson et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291718002039
Downloaded from https://www.cambridge.org/core. IU Health Medical Library, on 31 Jan 2019 at 16:55:45, subject to the Cambridge Core terms of use, available at
SNP-based estimate of OCD was based on a clinical sample of
most severe and therefore probably most genetically loaded
cases. Yet, standard errors for both the family-based and
SNP-based estimate of OCD were relatively large, so these find-
ings should be interpreted with caution. In a similar vein, one
should not stretch the interpretation of the SNP based AD esti-
mate as it derives from one of the smaller genetic samples.
The family-based estimates showed substantial differences in
the relative contributions of genes and environment across the
eight psychiatric conditions: Heritability estimates for AD, AN,
MDD, and OCD were relatively low, ranging from 30 to 41%.
However, the prevalence of AN in the family data was low and
hence, statistical power was limited, as illustrated by the large
standard error in these data. Still, the estimate of 41% for AN
in the family data confirms heritability estimates based on twin
studies (Polderman et al., 2015), also in clinical samples
(Mazzeo et al., 2009). Heritability estimates of ADHD, ASD,
BIP, and SCZ showed the highest narrow-sense heritability esti-
mates between 51 and 80%. With the dramatic increase in sample
sizes, the recent endeavors to identify genes that could explain the
heritability of psychiatric disorders is becoming more successful.
For instance, 108 significantly associated genetic loci were identi-
fied for SCZ in a sample of almost 37 000 cases and over 113 000
controls (Schizophrenia Working Group of the Psychiatric
Genomics Consortium, 2014). Follow-up analyses on biological
pathways revealed that some of the associated genes play an
important role in the immune system. However, high heritability
not necessarily implies that genetic associations are easy to detect.
For example, a recent study in 16 539 ASD cases and over 150 000
controls resulted in only one associated genetic locus (Warrier
et al., 2017). Similarly, for ADHD only very recently the first 12
associated genetic loci have been published (Demontis et al.,
2017), illustrating that gene identification in the psychiatric
domain is a long and complex avenue.
The fact that heritability estimates show variation across disor-
ders and is never estimated >90% indicates that, discounting
potential measurement error, stochasticity, and non-definable
environmental factors, definable environmental factors might
play an important role in the etiology of psychiatric disorders.
In particular, for AD, AN, MDD, and OCD with heritability esti-
mates <50%, environmental etiological research might elucidate
crucial pathways that significantly increase the risk for these traits.
In addition, gene by environment interaction will likely play a role
in the development of psychiatric disorders (Uher and Zwicker,
2017). For instance, one study showed that the effect of a genetic
risk for MDD increased in individuals with childhood trauma
(Peyrot et al., 2014). In other words, given a genetic vulnerability,
exposure to certain environmental risk factors will increase the
risk for disorder development. However, two recent larger studies
(Mullins et al., 2016; Peyrot et al., 2017) showed no interaction
effect. All in all, the empirical evidence for gene by environment
interaction in psychiatric disorders is as yet limited (Wray and
Maier, 2014) but increasing sample sizes and careful assessments
of environmental risk factors are crucial in future research aiming
to elucidate causal routes in psychiatric disorders.
Limitations
Our study has potential limitations. First, the concept of shared
environment is not straightforward in the sibling design.
Siblings are born at different points in time, do not share the pre-
natal environment, and are born into different family structures
(e.g. the first child born to young parents v. the second child
born to older parents who already have one child). We aimed
to minimize potential time effects by limiting age differences
between siblings to a maximum of 5 years. Moreover, additional
analyses comparing siblings born within 1–2 v. 4–5 years apart
showed very similar results (data not shown). Second, in the
national sibling design, we assume that the shared environment
of full and half siblings is the same. This assumption seems cor-
rect: A recent study showed that the vast majority of both Swedish
full and maternal half-siblings tend to live together throughout
childhood (Pettersson et al., 2016). Third, the inclusion age
limit for the different disorders in the national sibling design
was relatively young (e.g. minimum age of 10 years old for AD,
AN, MDD, and OCD) to strike a balance between power on the
one hand, and clinical generalizability on the other. However,
we cannot rule out that children of that age develop such a dis-
order later in life. Yet, two additional sets of sensitivity analyses
in which only older subjects were included, showed very similar
results (online Tables A1 and A2). Fourth, the national sibling
cohort lacked information from primary care, which might result
in false negatives, in particular, for disorders from the internaliz-
ing spectrum and drug abuse (Sundquist et al., 2017). However,
this source of bias probably has limited influence on the heritabil-
ity estimates as it is unlikely to differentially impact full- v. mater-
nal half-siblings. Nevertheless, failure to include information from
primary care decreases power, and limits the generalizability of
the study results to the more severe forms of mental health pro-
blems that warrant attention by outpatient specialists and
inpatient services. Fifth, we compare family-based h2 estimates,
that were derived from a Swedish sample only, with h2-SNP
results that were based on a variety of cohorts. Although these
are all of the European descent, there might be heterogeneity in
h2-SNP between cohorts, which makes the comparison with
Swedish data less precise. We, therefore, examined heterogeneity
in estimates of SCZ, as for this disorder a large Swedish sample
contributed to the GWAS from which the h2-SNP was derived
(Schizophrenia Working Group of the Psychiatric Genomics
Consortium, 2014). Supplementary Table S7 of this study clearly
shows that the h2-SNP based on the Swedish cohort equals
h2-SNP estimates from other samples of similar size (i.e.
Germany, UK), suggesting that the Swedish data are fairly com-
parable with other data from European descent.
Lastly, both designs assume random mating but a large-scale
study in psychiatric populations (Nordsletten et al., 2016)
observed substantial non-random mating within and across disor-
ders. A recent study, however, concluded that non-random mat-
ing has only a very modest effect on SNP-based heritability
estimates in psychiatric traits (Peyrot et al., 2016b).
Conclusion
In sum, this study presents a converging picture of the etiology
of eight psychiatric disorders. SNP-based estimates were as
expected lower but correlated with the family-based estimates.
Additionally, the findings highlight large differences in genetic
and environmental influences between psychiatric disorders. In
contrast to ASD, ADHD, BIP, and SCZ, where genetic influences
are most important, non-genetic influences play a large role in
AD, AN, MDD, and OCD.
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Appendices
Sensitivity analyses
We conducted two sets of sensitivity analyses to examine whether the pre-
specified age of the second sibling might have been too young. First, we con-
ducted the analyses in the adult population only by including pairs in which
the youngest sibling was 20 years old or older. Results are displayed in
Table A1, and were very similar for all disorders except for OCD, for which
the heritability estimate decreased from 0.38 to 0.24. However, due to a lack
of maternal half-sibling cases, the standard error about this estimate was
0.20, indicating a lack of precision such that the two estimates did not differ
significantly.
Second, we plotted the distributions of the age at first diagnosis for each
disorder. We then re-ran the analyses but only included pairs where the
younger sibling was at least as old as the median age of diagnosis. This way,
the youngest siblings were more likely to have lived through the risk period
of onset. Results are displayed in Table A2, and show that the estimates are
remarkably similar to the original analyses (although the standard errors are
larger).
In sum, the heritability estimates remained very similar regardless of
whether we relied on our original age cutoffs, or on adults or the median
age of onset.
Psychological Medicine 7
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291718002039
Downloaded from https://www.cambridge.org/core. IU Health Medical Library, on 31 Jan 2019 at 16:55:45, subject to the Cambridge Core terms of use, available at
Table A1. H2 of psychiatric diagnoses based on ICD 8, 9, and 10 in adults of >19 years
Frequencies
Full siblings Maternal half-siblings Tetrachoric correlation
Cases Controls Prevalence (%) Cases Controls Prevalence (%) Full sibs Maternal half-sibs h2
Alcohol dependence 87 773 3 043 417 2.80 10 589 157 287 6.31 0.253 (0.004) 0.142 (0.012) 0.444 (0.052)
Anorexia nervosa 8067 3 123 123 0.26 657 167 219 0.39 0.207 (0.020) 0.120 (0.076) 0.349 (0.316)
Attention deficit hyperactivity disorder 5003 209 959 2.33 895 8927 9.11 0.445 (0.014) 0.175 (0.040) 0.852 (0.171)
Autism spectrum disorder 2430 212 532 1.13 237 9585 2.41 0.388 (0.022) 0.055 (0.098) 0.665 (0.402)
Bipolar disorder 18 655 3 112 535 0.60 1619 166 257 0.96 0.303 (0.009) 0.167 (0.038) 0.543 (0.158)
Major depressive disorder 121 015 3 010 175 3.86 12 377 155 499 7.37 0.194 (0.004) 0.117 (0.011) 0.307 (0.048)
Obsessive compulsive disorder 11 553 3 119 637 0.37 1003 166 873 0.60 0.228 (0.014) 0.167 (0.048) 0.244 (0.198)
Schizophrenia 15 178 3 116 012 0.48 1106 166 770 0.66 0.330 (0.010) 0.050 (0.058) 0.569 (0.049)
Note. Standard errors are presented in parentheses.
Sex and age was regressed out from all disorders.
For ADHD and Autism, birth year was limited to 1990 or higher.
Youngest sibling born at age 20 or later.
Table A2. H2 of psychiatric diagnoses based on ICD 8, 9 , and 10, with the younger sibling being at least as old as the median age of diagnosis
Frequencies
Full siblings Maternal half-siblings Tetrachoric correlation
Cases Controls Prevalence (%) Cases Controls Prevalence (%)
Median age of disorder
onset Full sibs Maternal half sibs h2
Schizophrenia 14 188 2 335 292 0.60 967 112 193 0.85 34 0.326 (0.010) 0.053 (0.059) 0.564 (0.050)
Bipolar 14 496 2 184 334 0.66 998 103 240 0.96 37 0.297 (0.011) 0.166 (0.048) 0.525 (0.197)
ADHD 10 452 408 760 2.49 2308 21 324 9.77 16 0.455 (0.009) 0.257 (0.024) 0.807 (0.104)
Autism 4900 414 312 1.17 653 22 979 2.76 16 0.410 (0.015) 0.223 (0.049) 0.748 (0.204)
MDD 82 840 2 063 646 3.86 6642 94 294 6.58 38 0.169 (0.004) 0.108 (0.016) 0.242 (0.065)
Anorexia 8706 3 277 732 0.26 700 177 898 0.39 16 0.211 (0.019) 0.115 (0.075) 0.375 (0.309)
OCD 9478 2 751 410 0.34 781 139 567 0.56 26 0.222 (0.016) 0.155 (0.053) 0.267 (0.220)
SUDS & Alcohol 66 035 2 080 451 3.08 6481 94 455 6.42 38 0.265 (0.005) 0 .177 (0.015) 0.351 (0.065)
Note. Standard errors are presented in parentheses.
Sex and age were regressed out from all disorders.
For ADHD and autism, birth year was limited to 1990 or higher.
Youngest sibling being at least as old as disorder median age of onset or later.
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